Download - WHOCC

QC01D
VASODILATORS USED IN CARDIAC DISEASES
Preparations used in ischemic heart disease are classified in this group. See also
QC02, QC03, QC04, QC07, QC08 and QC09.
Combinations with cardiac glycosides, see QC01A.
Combinations with rauwolfia alkaloids, see QC02AA.
Combinations with beta blocking agents, see QC07.
Combinations with calcium channel blockers, see QC08.
QC01DA
Organic nitrates
Amyl nitrite is classified in QV03AB - Antidotes.
Combinations of isosorbide dinitrate and hydralazine are classified in
QC01DA58.
QC01DB
QC01DX
Quinolone vasodilators
Other vasodilators used in cardiac diseases
Vasodilators used in cardiac diseases which cannot be classified in the preceding
groups should be assigned to this group.
QC01E
OTHER CARDIAC PREPARATIONS
Various preparations used in the treatment of ischemic heart disease, which
cannot be classified in any of the preceding groups should be assigned to this
group.
QC01EA
QC01EB
Prostaglandins
Other cardiac preparations
Plain preparations used in the treatment of ischemic heart diseases, which cannot
be classified in the preceding groups should be assigned to this group.
Other cardiovascular agents which cannot be classified in ATC group QC02-
QC09 are also classified here.
QC01EX
Other cardiac combination products
Combined preparations, which cannot be classified in the preceding groups,
should be assigned to this group.
49